Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Cell & Gene Therapy

Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies
JW Therapeutics Completes $300 Million Hong Kong IPO for CAR-T Products
Gracell Closes $100 Million C Funding for Novel CAR-T Technologies
Siranomics Closes $105 Million Funding from China Investors; Plans IPO
Beijing Immunochina Raises $15 Million for CAR-T Portfolio
Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021